Hyperandrogenism Induces Histo-Architectural Changes in the Rat Uterus

Area of Science:

• Reproductive Endocrinology
• Gynecological Pathology
• Cell Biology

Background:

• Androgen excess, common in polycystic ovary syndrome (PCOS), is linked to endometrial hyperplasia, cancer, and infertility.
• The specific effects of androgens on uterine histomorphology remain poorly understood.
• Clarifying these effects is crucial for understanding PCOS-related reproductive complications.

Purpose of the Study:

• To investigate the impact of dehydroepiandrosterone (DHEA)-induced hyperandrogenism on uterine architecture in an experimental PCOS model.
• To elucidate the cellular and extracellular changes in the uterus under conditions of elevated androgens.
• To explore potential mechanisms, including extracellular matrix remodeling and water imbibition, contributing to uterine alterations.

Main Methods:

• Female rats were administered daily dehydroepiandrosterone (DHEA) or vehicle from weaning for 20 days.
• Uterine histomorphology, including epithelial height, glandular density, stromal and myometrial thickness, and cell proliferation, was assessed.
• Analysis included extracellular space, collagen fiber organization, water content, and aquaporin expression.

Main Results:

• DHEA treatment led to elevated serum testosterone levels and increased uterine luminal epithelial height and glandular density.
• Significant increases in subepithelial stromal and myometrial thickness were observed, associated with reduced cell density.
• Changes in uterine thickness were linked to enhanced collagen fiber organization and water imbibition, evidenced by increased aquaporin 3 and 8 expression.

Conclusions:

• DHEA-induced hyperandrogenism significantly alters uterine architecture, characterized by increased thickness and altered extracellular matrix.
• These structural changes, involving collagen organization and water retention, may contribute to the pathogenesis of PCOS-associated uterine pathologies.
• Understanding these androgen-driven uterine modifications is vital for addressing endometrial hyperplasia, cancer, and infertility in PCOS.